Indications and uses
For treatment of acne.
For treatment of acne.
Clean the skin thoroughly before applying this product. Apply to areas of congestion, and allow 3-5 minutes to fully activate. Rinse thoroughly with tepid water, and follow with your moisturizer.
Salicylic Acid 1.1%
Acne Treatment
For treatment of acne.
For external use only.
Protect the product in this container from excessive heat and direct sun.
WATER (AQUA), KAOLIN, DISILOXANE, GLYCERIN, DIPROPYLENE GLYCOL, COCAMIDOPROPYL BETAINE, DISODIUM COCOYL GLUTAMATE, BETAIN, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, SODIUM HYDROXIDE, 1,2-HEXANEDIOL, HYDROXYACETOPHENONE, XANTHAN GUM, POLYSORBATE 20, BUTYLENE GLYCOL, SODIUM CHLORIDE, FRAGRANCE (PARFUM), DIMETHICONE, FORSYTHIA SUSPENSA FRUIT EXTRACT, PUERARIA LOBATA ROOT EXTRACT, ANEMARRHENA ASPHODELOIDES ROOT EXTARCT, CAPRYLYL GLYCOL PENITYLRNR GLYCOL, CARAMEL, TURPENTINE, PINENE.
1-212-244-5170
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1c9d1af-bddd-448d-86f7-69052b7d5b47 | Product name | 1 | 20220627 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85179-008-00 | SOS Rituals Pore Pop Fizz Mask Blackhead Treatment | 50 mL in 1 BOTTLE, PUMP | LOTION | 50 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 85179-008 | 85179-008-00 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SOS Rituals Pore Pop Fizz Mask Blackhead Treatment | SALICYLIC ACID | I World LLC | 692a7c40-7b55-4e53-9e06-60052d96f4cb | 2025-03-17 | Warnings | 85179-008-00 85179-008 85179000800 308d602b-c8de-575c-e063-6394a90a1d07 692a7c40-7b55-4e53-9e06-60052d96f4cb |
Adverse event summaries are temporarily unavailable. Other product information remains available.